APOL1 High-Risk Genotype is Not Associated With New or Worsening of Proteinuria or Kidney Function Decline Following COVID-19 Vaccination
Introduction: SARS-CoV-2 infection increases systemic inflammatory cytokines which act as a second-hit driver of Apolipoprotein L1 (APOL1)-mediated collapsing glomerulopathy. SARS-CoV-2 vaccination also increases cytokines. Recent reports of new glomerular disease in individuals with APOL1 high-risk...
Saved in:
| Main Authors: | Sarah E. Nystrom, Karen L. Soldano, Micki Rockett, Somenath Datta, Guojie Li, Daniel Silas, Melanie E. Garrett, Allison E. Ashley-Koch, Opeyemi A. Olabisi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924017996 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1–Mediated Kidney Disease (JUSTICE)
by: Opeyemi A. Olabisi, et al.
Published: (2024-09-01) -
Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell Injury
by: Razi Khalaila, et al.
Published: (2025-07-01) -
APOL4-mediated intracellular cholesterol trafficking is essential for glioblastoma cell growth
by: Mingxiang Zhang, et al.
Published: (2025-05-01) -
A Cell Biologist’s View on APOL1: What We Know and What We Still Need to Address
by: Verena Höffken, et al.
Published: (2025-06-01) -
Evaluation of Circulating APOL1 in Diabetes Mellitus Patients attending Aminu Kano Teaching Hospital
by: Jibril, A.A.*1, Gwarzo, M.Y.2, Abdullahi, H.L2., Babale, N.S3., Adamu, F.3., Khalid, U.M1., Halliru2, A.H., Jamilah, I.S3., Ahmed, A.Y3., Mahmud, R.I.5, Usman, M.M. 3.
Published: (2025-05-01)